Alta Fundamental Advisers LLC Cyteir Therapeutics, Inc. Transaction History

Alta Fundamental Advisers LLC

  • $226 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$2.71 - $2.84 $318,007 - $333,262
117,346 New
117,346 $333,000

Others Institutions Holding CYT

# of Institutions
2
Shares Held
2.47M
Call Options Held
0
Put Options Held
0
View Full List

About Cyteir Therapeutics, Inc.

CYT Quotes by TradingView
  • Ticker CYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,413,400
  • Market Cap $107M
  • Description
  • Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...
More about CYT
Track This Portfolio

Track Alta Fundamental Advisers LLC Portfolio

Follow Alta Fundamental Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Fundamental Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alta Fundamental Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email